HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education
HealthEquity (Nasdaq: HQY), the largest HSA and consumer-directed benefits administrator in the US, has received multiple prestigious awards for its AI-powered educational tool HSAnswers. Launched in October 2024, the tool has won the 2025 AI Breakthrough Award for Informational Bot Solution of the Year and two Globee Silver Awards.
HSAnswers leverages over 500 educational resources and 20 years of industry expertise to provide instant, personalized answers about HSAs and other consumer-directed benefits. The tool addresses a critical market need, as 73% of employees seek improved benefits education. Available freely at healthequity.com/hsanswers, the platform has already facilitated hundreds of thousands of conversations since launch.
HealthEquity (Nasdaq: HQY), il principale amministratore di HSA e di benefit a gestione diretta per i consumatori negli Stati Uniti, ha ottenuto numerosi riconoscimenti per il suo strumento educativo basato sull'IA, HSAnswers. Lanciato nell'ottobre 2024, lo strumento ha vinto il 2025 AI Breakthrough Award come Informational Bot Solution of the Year e due Globee Silver Awards.
HSAnswers sfrutta oltre 500 risorse didattiche e 20 anni di esperienza nel settore per offrire risposte istantanee e personalizzate su HSA e altri benefit a gestione diretta. Risponde a un'esigenza importante del mercato: il 73% dei dipendenti desidera una migliore educazione sui benefit. Accessibile gratuitamente su healthequity.com/hsanswers, la piattaforma ha già gestito centinaia di migliaia di conversazioni dal lancio.
HealthEquity (Nasdaq: HQY), el mayor administrador de HSA y beneficios dirigidos al consumidor en EE. UU., ha recibido varios premios por su herramienta educativa con IA, HSAnswers. Lanzada en octubre de 2024, la herramienta ganó el 2025 AI Breakthrough Award a Informational Bot Solution of the Year y dos Globee Silver Awards.
HSAnswers utiliza más de 500 recursos educativos y 20 años de experiencia en el sector para ofrecer respuestas instantáneas y personalizadas sobre HSA y otros beneficios dirigidos al consumidor. Atiende una necesidad crítica del mercado: el 73% de los empleados busca mejor educación sobre beneficios. Disponible gratuitamente en healthequity.com/hsanswers, la plataforma ya ha facilitado cientos de miles de conversaciones desde su lanzamiento.
HealthEquity (Nasdaq: HQY)� 미국에서 가� � HSA � 소비� 지향형 복리후생 관리자이며, AI 기반 교육 도구 HSAnswers� 여러 권위 있는 상을 받았습니�. 2024� 10월에 출시� � 도구� Informational Bot Solution of the Year 부문에� 2025 AI Breakthrough Award� 수상했고, � 개의 Globee Silver Awards� 받았습니�.
᳧Բɱ� 500� 이상� 교육 자료와 20년의 업계 노하우를 활용� HSA � 기타 소비� 지향형 복리후생� 대� 즉각적이� 개인화된 답변� 제공합니�. 시장� 중요� 요구� 충족하는�, 직원� 73%가 복리후생 교육 개선� 원합니다. healthequity.com/hsanswers에서 무료� 이용� � 있으�, 출시 이후 수십� 건의 대화를 이미 지원했습니�.
HealthEquity (Nasdaq: HQY), le principal gestionnaire d'HSA et d'avantages orientés consommateur aux États-Unis, a reçu plusieurs distinctions pour son outil éducatif IA, HSAnswers. Lancé en octobre 2024, l'outil a remporté le 2025 AI Breakthrough Award dans la catégorie Informational Bot Solution of the Year ainsi que deux Globee Silver Awards.
HSAnswers s'appuie sur plus de 500 ressources pédagogiques et 20 ans d'expertise sectorielle pour fournir des réponses instantanées et personnalisées sur les HSA et autres avantages orientés consommateur. Il répond à un besoin majeur du marché : 73 % des employés souhaitent une meilleure formation sur les avantages. Accessible gratuitement sur healthequity.com/hsanswers, la plateforme a déjà facilité des centaines de milliers de conversations depuis son lancement.
HealthEquity (Nasdaq: HQY), der größte Verwalter von HSAs und verbraucherorientierten Leistungen in den USA, hat für sein KI-gestütztes Lernwerkzeug HSAnswers mehrere renommierte Auszeichnungen erhalten. Das im Oktober 2024 eingeführte Tool gewann den 2025 AI Breakthrough Award als Informational Bot Solution of the Year sowie zwei Globee Silver Awards.
HSAnswers nutzt über 500 Bildungsressourcen und 20 Jahre Branchenerfahrung, um sofortige, personalisierte Antworten zu HSAs und anderen verbraucherorientierten Leistungen zu liefern. Es deckt einen wichtigen Marktbedarf ab, denn 73 % der Beschäftigten wünschen sich bessere Informationen zu Leistungen. Kostenlos verfügbar unter healthequity.com/hsanswers hat die Plattform seit dem Start bereits Hunderttausende von Gesprächen ermöglicht.
- None.
- None.
Industry Leader’s HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions
DRAPER, Utah, Aug. 29, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: HQY), the nation’s largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced that its innovative AI-powered educational tool, , has received multiple prestigious industry awards recognizing its excellence in artificial intelligence and benefits education innovation.
HSAnswers is designed to provide fast and reliable responses to HSAs questions and other consumer-directed benefits (CDBs). The tool uses generative artificial intelligence to deliver personalized conversation and insights powered by HealthEquity's comprehensive knowledge base and industry expertise.
Since in October 2024, HSAnswers has garnered industry recognition, including the 2025 AI Breakthrough Awards for Informational Bot Solution of the Year; 2025 Globee Silver Winner for Artificial Intelligence Achievement of the Year; and 2025 Globee Silver Winner for AI-based Solution for Healthcare. These accolades highlight HSAnswers' groundbreaking approach to making complex healthcare benefits more accessible and understandable for millions of Americans.
Advanced Technology Meets AG˹ٷ-World Impact
HSAnswers has already demonstrated remarkable impact since its launch, facilitating hundreds of thousands of conversations. The platform addresses real-world questions that matter to healthcare consumers, from practical inquiries like "Can I use my HSA to pay for teeth aligners?" to complex scenarios such as "I am turning 65 at the end of the year and will be signing up for Medicare for 2026—am I able to contribute to my HSA account this year through 2025?" This sustained engagement reflects the tool's ability to provide meaningful guidance that addresses a critical marketplace need, where
“While the marketplace floods with generic AI tools, HSAnswers distinguishes itself through its deep expertise in consumer-directed benefits and ability to simplify complexity by providing instant, personalized answers without requiring users to navigate through extensive documentation," said Shuki Licht, HealthEquity Head of Innovation and VP of AI Tech. "When employees during enrollment, they're inevitably left with questions. We're leveraging AI to solve real problems impacting millions of Americans' healthcare decisions, continuing to elevate our members� experiences and delivering answers efficiently at scale when people need them most.�
Transforming Benefits Education Through AI Innovation
The tool leverages over 500 curated HealthEquity educational resources and its comprehensive knowledge base powered by more than 20 years of industry expertise and leadership, those that query HSAnswers can depend on its reliable and contextually relevant information about HSAs and other CDBs including FSAs, HRAs, and LSAs. The company continues investing in the tool and aims to include even more sophisticated use cases to elevate member experiences in the coming months.
HSAnswers is freely available to anyone at healthequity.com/hsanswers including current and prospective HealthEquity members, benefits administrators, brokers, consultants, and health plan partners. Start asking questions now at .
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to save and improve lives by empowering healthcare consumers. For more information, visit
Media Contact
Atiya Easterling
